Sjøgren's syndrome-associated oxidative stress and mitochondrial dysfunction: Prospects for chemoprevention trials

References

• Fox RI. Sjögren's syndrome. Lancet 2005;366:321–331.
   PubMed Web of Science ®Google Scholar
• Skopouli FN, Barbatis C, Moutsopoulos HM. Liver involvement in primary Sjögren's syndrome. Br J Rheumatol 1994; 33:745–748.
   PubMedGoogle Scholar
• Ikuno N, Mackay IR, Jois J, Omagari K, Rowley MJ. Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis. J Gastroenterol Hepatol 2001; 16:1390–1394.
   Google Scholar
• Hansen A, Lipsky PE, Dorner T. B-cell lymphoproliferation in chronic inflammatory rheumatic diseases. Nat Clin Pract Rheumatol 2007;3:561–569.
   PubMedGoogle Scholar
• Voulgarelis M, Skopouli FN. Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's Syndrome patients. Clinic Rev Allerg Immunol 2007;32:265–274.
   PubMed Web of Science ®Google Scholar
• Bikker A, van Woerkom JM, Kruize AA, Wenting-van Wijk M, de Jager W, Bijlsma JW, . Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation. Arthritis Rheum 2010;62:969–977.
   PubMed Web of Science ®Google Scholar
• Baturone R, Soto MJ, Márquez M, Macías I, de Oca MM, Medina F, . Health-related quality of life in patients with primary Sjögren's syndrome: relationship with serum levels of proinflammatory cytokines. Scand J Rheumatol 2009;38:386–389.
   PubMed Web of Science ®Google Scholar
• Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's Syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol 2008;181:2898–2906.
   PubMed Web of Science ®Google Scholar
• Lindholm C, Acheva A, Salomaa S. Clastogenic plasma factors: a short overview. Radiat Environ Biophys 2010;49:133–138.
   Google Scholar
• Obrador E, Navarro J, Mompo J, Asensi M, Pellicer JA, Estrela JM. Regulation of tumour cell sensitivity to TNF-α induced oxidative stress and cytotoxicity: role of glutathione. Biofactors 1998;8:23–26.
   PubMedGoogle Scholar
• Chung HY, Lee EK, Choi YJ, Kim JM, Kim DH, Zou Y, . Molecular inflammation as an underlying mechanism of the aging process and age-related diseases. J Dent Res 2011;90: 830–840.
   Google Scholar
• Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked?Free Radic Biol Med 2010;49:1603–1616.
   PubMed Web of Science ®Google Scholar
• Elmarakby AA, Sullivan JC. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther 2012;30:49–59.
   PubMed Web of Science ®Google Scholar
• Torsteinsdóttir I, Gudbjörnsson B, Håkansson L. Enhanced neutrophil and eosinophil adhesion in patients with primary Sjögren's syndrome. Clin Exp Rheumatol 1998;16:255–262.
   PubMedGoogle Scholar
• Barnes TC, Anderson ME, Edwards SW, Moots RJ. Neutrophil-derived reactive oxygen species in SSc. Rheumatology (Oxford) 2012;51:1166–1169.
   Google Scholar
• Kurimoto C, Kawano S, Tsuji G, Hatachi S, Jikimoto T, Sugiyama D, . Thioredoxin may exert a protective effect against tissue damage caused by oxidative stress in salivary glands of patients with Sjögren's syndrome. J Rheumatol 2007;34:2035–2043.
   PubMed Web of Science ®Google Scholar
• Norheim KB, Jonsson G, Harboe E, Hanasand M, Gøransson L, Omdal R. Oxidative stress, as measured by protein oxidation, is increased in primary Sjøgren's syndrome. Free Radic Res 2012;46:141–146.
   PubMed Web of Science ®Google Scholar
• Ryo K, Yamada H, Nakagawa Y, Tai Y, Obara K, Inoue H, . Possible involvement of oxidative stress in salivary gland of patients with Sjogren's syndrome. Pathobiology 2006;73: 252–260.
   PubMed Web of Science ®Google Scholar
• Cay HF, Sezer I, Dogan S, Felek R, Aslan M. Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha, myeloperoxidase and nitrotyrosine in primary Sjögren's Syndrome. Clin Exp Rheumatol 2012 May 18. [Epub ahead of print] PMID: 22703762
   Google Scholar
• Cui G, Wang H, Li R, Zhang L, Li Z, Wang Y, . Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke. J Neuroinflammation 2012;9:235.
   PubMed Web of Science ®Google Scholar
• Shimizu K, Ogawa F, Akiyama Y, Muroi E, Yoshizaki A, Iwata Y, . Increased serum levels of N(epsilon)-(hexanoyl)lysine, a new marker of oxidative stress, in systemic sclerosis. J Rheumatol 2008;35:2214–2219.
   Google Scholar
• Cejková J, Ardan T, Simonová Z, Cejka C, Malec J, Dotrelová D, . Decreased expression of antioxidant enzymes in the conjunctival epithelium of dry eye (Sjögren's syndrome) and its possible contribution to the development of ocular surface oxidative injuries. Histol Histopathol 2008;23:1477–1483.
   PubMed Web of Science ®Google Scholar
• Lee J, Giordano S, Zhang J. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J 2012;441:523–540.
   PubMed Web of Science ®Google Scholar
• Lenaz G. Mitochondria and reactive oxygen species. Which role in physiology and pathology?Adv Exp Med Biol 2012; 942:93–136.
   PubMed Web of Science ®Google Scholar
• Addabbo F, Montagnani M, Goligorsky MS. Mitochondria and reactive oxygen species. Hypertension 2009;53: 885–892.
   PubMed Web of Science ®Google Scholar
• Lambert AJ, Brand MD. Reactive oxygen species production by mitochondria. Methods Mol Biol 2009;554:165–181.
   PubMedGoogle Scholar
• Escames G, López LC, García JA, García-Corzo L, Ortiz F, Acuña-Castroviejo D. Mitochondrial DNA and inflammatory diseases. Hum Genet 2012;131:161–173.
   PubMed Web of Science ®Google Scholar
• Pallardó FV, Lloret A, Lebel M, d’Ischia M, Cogger VC, Le Couteur DG, . Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome. Biogerontology 2010;11:401–419.
   PubMed Web of Science ®Google Scholar
• Fujikura S, Davis PA, Prindiville T, Leung P, Fox RI, Gershwin ME. Sjögren's syndrome and primary biliary cirrhosis: presence of autoantibodies to purified mitochondrial 2-OXO acid dehydrogenases. J Rheumatol 1990; 17:1453–1457.
   PubMed Web of Science ®Google Scholar
• Perl A, Fernandez DR, Telarico T, Doherty E, Francis L, Phillips PE. T-cell and B-cell signaling biomarkers and treatment targets in lupus. Curr Opin Rheumatol 2009;21:454–464.
   PubMed Web of Science ®Google Scholar
• Gorąca A, Huk-Kolega H, Piechota A, Kleniewska P, Ciejka E, Skibska B. Lipoic acid - biological activity and therapeutic potential. Pharmacol Rep 2011;63:849–858.
   PubMed Web of Science ®Google Scholar
• Quinzii CM, Hirano M. Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev 2010;16:183–188.
   PubMed Web of Science ®Google Scholar
• Chaturvedi RK, Beal MF. Mitochondrial approaches for neuroprotection. Ann N Y Acad Sci 2008;1147:395–412.
   PubMed Web of Science ®Google Scholar
• Smith RA, Adlam VJ, Blaikie FH, Manas AR, Porteous CM, James AM, . Mitochondria-targeted antioxidants in the treatment of disease. Ann N Y Acad Sci 2008;1147: 105–111.
   PubMed Web of Science ®Google Scholar
• Gu XM, Zhang SS, Wu JC, Tang ZY, Lu ZQ, Li H, . Efficacy and safety of high-dose α-lipoic acid in the treatment of diabetic polyneuropathy. Zhonghua Yi Xue Za Zhi 2010;90:2473–2476.
   Google Scholar
• Zhang Y, Han P, Wu N, He B, Lu Y, Li S, . Amelioration of lipid abnormalities by α-lipoic acid through antioxidative and anti-inflammatory effects. Obesity (Silver Spring) 2011; 19:1647–1653.
   PubMed Web of Science ®Google Scholar
• Koh EH, Lee WJ, Lee SA, Kim EH, Cho EH, Jeong E, . Effects of alpha-lipoic acid on body weight in obese subjects. Am J Med 2011;124:85.e1–e8.
   Google Scholar
• Tiano L, Carnevali P, Padella L, Santoro L, Principi F, Brugè F, . Effect of Coenzyme Q(10) in mitigating oxidative DNA damage in Down syndrome patients, a double blind randomized controlled trial. Neurobiol Aging 2011; 32:2103–2105.
   Google Scholar
• Cordero MD, Díaz-Parrado E, Carrión AM, Alfonsi S, Sánchez-Alcázar JA, Bullon P, . Is inflammation a mitochondrial dysfunction-dependent event in Fibromyalgia? Antioxid Redox Signal 2012 Sep 3. [Epub ahead of print].
   Google Scholar